Metformin XR
Metformin XR is a pharmaceutical drug with 30 clinical trials. Currently 4 active trials ongoing. Historical success rate of 91.3%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
3
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
21 of 24 finished
12.5%
3 ended early
4
trials recruiting
30
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
Clinical Trials (30)
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity
An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets
A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
A Study of LY900020 in Healthy Chinese Participants
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
Randomized Sitagliptin Withdrawal Study (MK-0431-845)
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise
Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 30